Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture, and commercialize HRS-5346 worldwide, excluding the Greater China region. Hengrui Pharma will ...

Data on federal individual contributions downloaded from the Federal Election Commission on 02/06/2025. State and local contributions are uploaded on a rolling basis. Federal law prohibits the use of ...

She said the firm was looking at ways of shedding its 'Big Bad Pharma' image, but conceded that there were no easy answers. The spokesperson also expressed some envy at the admiration Apple gets ...

Spurious drug manufacturers from other states are tarnishing the image of state’s pharmaceutical industry by using fictitious names of firms located in Himachal Pradesh. A recent case which ...

(Image Credits: Pixabay ... Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.

Check out the image below, which I created and downloaded with Reve Image. It looks like a real photo of a woman engaged in some sort of conflict in a snowy setting. I know, it’s strange ...

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday ... companies in the two sectors Tuesday. For example, Merck signed a deal to license a potential blockbuster ...

However, gains were capped as investors booked profits following last week’s sharp rally, while PSU bank and pharma stocks weighed on sentiment. The broader market showcased weak trends ...

The company’s chatbot can now create elaborate and unusual images. By Cade Metz Reporting from San Francisco Chatbots were originally designed to chat. But they can generate images, too.

Experimental drugs make a notable contribution to how much and how quickly each of these Big Pharma players ... While Merck shares are significantly below the VWAP, there is also an unclosed ...